Edition:
India

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

8.14USD
13 Jul 2018
Change (% chg)

$0.35 (+4.49%)
Prev Close
$7.79
Open
$7.83
Day's High
$8.17
Day's Low
$7.83
Volume
92,050
Avg. Vol
232,227
52-wk High
$9.86
52-wk Low
$1.32

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: --
Market Cap(Mil.): $220.52
Shares Outstanding(Mil.): 31.75
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -1.11 -- --
ROI: -85.78 15.07 14.61
ROE: -92.43 16.60 16.34

BRIEF-Marinus Pharmaceuticals Provides Business Update And 2017 Financial Results

* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND 2017 FINANCIAL RESULTS

06 Mar 2018

Earnings vs. Estimates